Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Connect Biopharma Holdings (CNTB) Operating Margin (2024 - 2025)

Connect Biopharma Holdings' Operating Margin history spans 2 years, with the latest figure at 110481.25% for Q3 2025.

  • For Q3 2025, Operating Margin fell 10934540.0% year-over-year to 110481.25%; the TTM value through Sep 2025 reached 7306.3%, changed N/A, while the annual FY2024 figure was 86.24%, N/A changed from the prior year.
  • Operating Margin for Q3 2025 was 110481.25% at Connect Biopharma Holdings, down from 1378.08% in the prior quarter.
  • Across five years, Operating Margin topped out at 1135.85% in Q3 2024 and bottomed at 110481.25% in Q3 2025.